This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

This Surgeon Isn't Falling Out of Love With Intuitive Surgical Or Its Robots

Stocks in this article: ISRG

The attention-seeking Johns Hopkins surgeon Dr. Martin Makary says hospitals and other surgeons are keeping safety problems with robotic surgeries quiet. I can assure Dr. Makary there is no secret cabal of surgeons underreporting problems --we are not that interested or organized to do so.

Surgical robots like da Vinci are designed with redundant systems to curtail problems, including emergency stop buttons, web-based connections to a central server monitored by Intuitive Surgical, technicians on call 24 hours per day and manual ways to disengage the machine. Remember these robots are actually master-slave machines, meaning they're not free thinking or autonomous. Rather, the robots only do what surgeons like myself tell them to do with our fingers.

Crappy surgeons get crappy outcomes from surgery, whether they're performing procedures with a robot or with their own hands. Post-operative problems (including horrible deaths) happen all the time. That's the fault of the surgeon, not the robots. To err is human, to blame the robot is ridiculous.

An Intuitive Surgical bear told me via Twitter that he heard of a case where the robotic arm "could not be disengaged." Perhaps, but that's because the surgeon operating the robot is an idiot. It would take me two seconds to manually disengage a robotic arm. Another tweeter told me, "The patient's OR table was moved and the robotic arm punctured a piece of intestine." Again, the surgeon is to blame. How is the unfortunate incident, if it actually happened, the fault of the surgical robot? Look, I don't deny there are terrible stories of surgical mishaps out there, but the blame is on wayward physicians, not a machine.

What of the JAMA article crushing the gynecologists? Has anyone read it? I did, and let me say, if I was a woman with an ailing uterus, I would be running to get a robotically assisted hysterectomy. Why? Patients who got the robot left the hospital earlier. I would do anything to leave the hospital earlier. The complications rates between robot-assisted and "traditional" surgery were the same (see above nonsense about the FDA reports.) The only problem was the robot appeared to cost more. Guess what? Patients don't care about cost and surgeons don't either. As a practicing surgeon, do you want me to worry about cost when I'm standing over your loved one in the operating room? Or, would you rather I care more about producing a more favorable outcome? Outcome is going to trump cost every time. I will let others decide whether cost issues will eventually hurt the long-term health of Intuitive Surgical's stock price, but the use of the robot is unlikely to change with this JAMA paper.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,667.24 -5.36 -0.03%
S&P 500 2,051.83 +0.01 0.00%
NASDAQ 4,756.7640 -1.1150 -0.02%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs